A $5.3 million National Institutes of Health grant awarded to the University of Oklahoma Health Sciences will support advanced cancer research in Oklahoma. The Centers of Biomedical Research Excellence (COBRE) grant is designed to build research capacity and help early-career researchers establish independently funded laboratories.
Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference – Biotech Investments
Rancho Cucamonga, 08/28/2024 / 13:10, PST/PDT – EQS Newswire – Amphastar Pharmaceuticals, Inc. Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Tony